Latest News

Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants

Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026

As Diesel Prices Hit Record Highs, Leaders Helping Scale Renewable Natural Gas as a Clean Alternative Receive Energy Vision Awards

AGNC Investment Corp. Announces Third Quarter 2026 Financial Results

Thomson Reuters Provides Supplemental Financial Information Following Close of Global Print Transaction

City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification

Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026